Ectopic genes transferred to cells are temporally expressed, although this phenomenon has not yet been well characterized. We found that 5-bromodeoxyuridine dramatically increased transient expression of ectopic genes in human cells. This effect was elicited by adding 5-bromodeoxyuridine prior to or after transfection. No promoter specificity was observed. Real time PCR analysis showed an approximately 2-fold increase in mRNA levels. Since 5-bromodeoxyuridine decondenses heterochromatin and changes the nuclear envelope, these changes might affect transcriptional and posttranscriptional events in the gene expression of plasmids.
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Key words: 5-bromodeoxyuridine; ectopic genes; pregnancy-specific glycoproteins; transient expression 5-Bromodeoxyuridine (BrdU) is normally incorporated into DNA as 5-bromouracil instead of thymine, and is widely used to measure DNA synthesis immunochemically in tissues and cultured cells. At modest concentrations, BrdU is not mutagenic and does not affect growth over several days in culture. Mutants isolated from Syrian hamster cells grow normally with BrdU as sole thymine source. 1) However, BrdU immediately and gradually perturbs a number of biological functions inside cells. Many reports have shown that BrdU can induce or inhibit cellular differentiation in various cell types. [2] [3] [4] [5] We have found that BrdU clearly induces a senescence-like phenomenon in mammalian cells regardless of cell type or species.
6) 5-Chlorodeoxyuridine can induce the same phenomena, and does so more clearly than BrdU. 7) Unlike BrdU, 5-chlorodeoxyuridine showed no cytotoxicity even when cells were heavily exposed to light following culture in its presence. 7) To date, various attempts have been made to find a molecular basis for the biological actions of BrdU. The majority have focused on changes in interaction between 5-bromouracil-substituted DNA and DNA-binding proteins. [8] [9] [10] But, we have suggested a different and more plausible scenario to the effect that BrdU changes DNA topology and nucleosome positioning, thus affecting chromatin structure. [11] [12] [13] [14] 5-Bromouracil-substitution in AT-rich sequences reduces their bending capacity, intensifies their interaction with nuclear matrix proteins, 15) and changes nucleosome assembly on model plasmids in yeast cells (K. Miki et al., manuscript in preparation).
In this study, we examined an effect of BrdU on transient expression of luciferase reporter constructs in human cells using two types of promoters, one derived from BrdU-inducible genes and the other from non BrdU-inducible genes. In the former case, we used promoter sequences of the PSG1 (À416/+107), PSG4 (À355/+66), and PSG11 (À364/+12) genes, 16) which encode pregnancy-specific glycoproteins PSG1, PSG4, and PSG11 respectively. In the latter case, we used those of -actin (À559/+39), glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (À584/+65), and vimentin (À545/+79) genes. The promoter sequences were amplified from the respective genomes by PCR and inserted into a luciferase reporter plasmid, pGL3-Basic, which can express luciferase mRNA driven by a inserted promoter. These plasmids were transfected to HeLa S3 cervical tumor cells by electroporation under standard conditions. The transfected cells were divided into several portions and cultured in plastic Petri dishes containing Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum and a test compound. 6) At intervals, the cells were harvested at approximately 50% confluence, and cell extracts were prepared to assay luciferase activity. 17) First we examined transient expression of constructs containing the PSG1, PSG4, and PSG11 promoter sequences during time courses after transfection and simultaneous addition of BrdU. Luciferase activity reached maximum levels 2 d after transfection with all of the constructs, and decreased gradually thereafter in the absence of BrdU (Fig. 1) . When BrdU was added to y To whom correspondence should be addressed. Fax: +81-45-820-1901; Tel: +81-45-820-1906; E-mail: dayusawa@yokohama-cu.ac.jp the cells, these time courses of activity did not change, but the activity of the construct containing the PSG1 promoter increased by 13-, 16-, and 27-fold, 2, 3, and 4 d respectively after the addition of BrdU. Similarly, the activity of the construct containing the PSG4 promoter increased by 14-, 16-, and 30-fold, and of construct containing the PSG11 promoter, by 10-, 12-, and 15-fold. The luciferase activity of the promoter-less plasmid was also increased, by approximately 5-6 fold by BrdU, although the levels were comparatively low. These results indicate that BrdU-inducible promoters are dramatically upregulated by BrdU in transient luciferase assay, but the effect did not appear to be restricted to the promoters of BrdU-inducible genes.
To examine promoter specificity, we used constructs containing -actin, GAPDH, and vimentin promoters in the transient luciferase assay. These promoters can drive constitutive expression of luciferase independently of the cell cycle. The luciferase activity of the construct containing the -actin promoter was increased by 13-, 17-, and 27-fold, 2, 3, and 4 d respectively after the addition of BrdU. Similarly, the activity of the construct containing the GAPDH promoter increased by 10-, 14-, and 25-fold, and that of the construct containing the vimentin promoter by 16-, 22-, and 44-fold ( Fig. 2A) . These results indicate that the marked stimulation of transient expression of the reporter constructs by BrdU does not depend on a specific type of promoter. We used another type of luciferase vector and obtained similar results, which indicates that this phenomenon is not specific to the type of plasmids. We examined a change in the levels of mRNA encoded by three plasmids differing in structure, by conventional and real-time PCR analyses. BrdU increased mRNA levels by approximately 2-fold (Fig. 2C) . Therefore, an additional posttranscriptional event may be required to explain the above mentioned effects of BrdU.
To date, we have presented several lines of evidence that BrdU changes chromatin structure. Hence, we tested other agents known to affect chromatin structure and gene expression (Fig. 2B) . We used trichostatin A, an inhibitor of histone deacetylase, 18) and 5-azacytidine, an inhibitor of DNA methylation. 19) When these agents were added up to 3 d after transfection, the luciferase activity of the construct containing the PSG4 promoter was upregulated by 4-fold by trichostatin A, but not by 5-azacytidine. Similarly, the activity of the construct containing the vimentin promoter was upregulated by 7-fold by trichostatin A, but not by 5-azacytidine. In both constructs, the levels of upregulation by trichostatin A were much less than by BrdU (15-to 19-fold).
We examined whether BrdU facilitates nuclear transport of ectopic DNA. We electroporated pGL3-Basic to HeLa cells before and after BrdU treatment, and separated the nuclei and cytoplasm to determine the contents of plasmid DNA with PCR. No plasmid DNA Luciferase reporter plasmid pGL3-Basic (Promega, Madison, Wisconsin) was digested with KpnI and BglII and ligated to promoter sequences of the PSG1, PSG4, and PSG11 genes. These plasmids were electroporated into HeLa cells with BTX electrocell manipulator ECM2001 at 450 V/cm for 1 Â 20 ms. The cells were aliquoted, and cultured in the presence of 50 mM BrdU for the times indicated to yield cell extracts at 50% confluence. 6) Luciferase activity was measured with a luminescence dosimeter and expressed as an average (luminescence intensity/30 s/ mg protein AE standard error) of at least four independent experiments, as described previously. 17) was detected in the cytoplasmic fractions in any case (Fig. 3B) . In the nuclear fractions, there was no significant difference in the amount of the plasmid DNA as between BrdU-treated and non-treated cells (Fig. 3A) . These results suggest that entrance of ectopic DNA into the nuclei cannot be the reason for the above phenomena.
In this study, we found that BrdU dramatically increases transient expression of transgenes independent of promoters. Several explanations are possible for this A, Transient expression assays with various promoters. Reporter plasmids containing the promoters indicated were electroporated into HeLa cells and cultured in the presence of 50 mM BrdU for 2 d to assay luciferase activity, as in Fig. 1 . B, Effects of some related compounds on transient expression of various promoters. Reporter plasmids pGL3-Basic, PSG4, vimentin, as indicated, were electroporated into HeLa cells and cultured in the presence of 50 mM BrdU, 0.3 mM trichostatin A (TSA), or 3 mM 5-azacytidine (5-AC) for 3 d to assay luciferase activity, as in Fig. 1 . C, Real time PCR analysis to determine mRNA levels. Experiments were done with a Smart Cycler (Cepheid, Sunnyvale, California) according to the supplier's instructions, as described elsewhere. 22) Crossing points (numbers of cycles required to reach noise band level) were calculated and plotted against the common logarithm of the standard copy number to generate a standard curve. Quantitative values of the samples, prepared from cells transected with various plasmids and cultured in the presence and absence of BrdU for 2 d, were calculated from the crossing points, and were expressed relative to controls. Vim luc vector, pGL3-Basic containing vimentin promoter; pcDNA3.1(À) RGS4, pcDNA3.1(À) (Invitrogen, CA) containing the RGS4 gene; pDsRed1-N1 Rab27b, pDsRed-N1 (Clontech) containing the Rab27b gene.
phenomenon. BrdU is known to cancel the bending of AT-rich sequences, and leads to a loosening of condensed chromatin. [12] [13] [14] These effects may help plasmids to pass through the cortical layer of heterochomatin located under the nuclear envelope and allow them access to nuclear regions where transcription is active. But, nuclear transport of ectopic DNA was not increased by BrdU. Trichostatin A did not lead to full expression of the reporter constructs, and 5-azacytidine had no effect. This may be related to the fact that trichostatin A and 5-azacytidine have lower effects in decondensing heterochromatin than BrdU. 13) Recently, we found that several proteins that shuttle between the cytoplasm and the nuclei are accumulated in the cytoplasm or in the nucleoplasm by the addition of BrdU. 20) Nuclear envelope proteins such as barrier to autointegration factor 21) have been found to be released from the nuclear envelope by addition of BrdU. These changes may increase the size of nuclear envelope regions where transcription is active, and may facilitate export of mRNA from the nucleus to the site of translation, resulting in an overall increase in expression of ectopic genes. The dramatic effect of BrdU described here should also be of practical use in studies using gene transfer or gene expression. pGL3-Basic was electroporated into HeLa cells cultured for 1 d before or 1d after culture in the presence of 50 mM BrdU. The cells were harvested 1d after the addition of BrdU, and nuclear and cytoplasmic fractions were prepared as described previously 23) to provide for PCR analysis. A, Determination of pGL3-Basic DNA in the nuclear factions of cells cultured in the presence or absence of BrdU. B, Determination of pGL3-Basic DNA in the cytoplasmic and the nuclear factions of cells cultured in the presence or absence of BrdU.
